Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization. 10.1111/j.1365-2672.2009.04361.x. This study was prompted to investigate the intestinal localization and colonization of orally administered Escherichia coli Nissle 1917 (EcN) in piglets. Methods and results: EcN was fed to ten EcN-negative piglets

Here, we investigated whether OMVs from the probiotic Escherichia coli strain Nissle 1917 or the commensal E. coli strain ECOR12 trigger immune responses in various cellular models: (i) peripheral blood mononuclear cells (PBMCs) as a model of intestinal barrier disruption, (ii) apical stimulation of Caco-2/PMBCs co-culture as a model of intact
Escherichia coli Nissle 1917 (EcN), a genetically tractable probiotic with a well-established human safety record, is emerging as a favored chassis. Here, we summarize the latest progress … Engineered microbes are rapidly being developed for the delivery of therapeutic modalities to sites of disease.
Probiotics are able to attenuate intestinal inflammation due to its immunomodulatory properties, being considered as safe when chronically administered. The aim was to test the association of minocycline, a tetracycline with immunomodulatory properties, and the probiotic Escherichia coli Nissle 1917 (EcN) in a mouse model of reactivated colitis.
Escherichia coli Nissle 1917 (EcN) is the active component of Mutaflor® (Ardeypharm GmbH, Herdecke, Germany), a pro- biotic drug licensed in several countries for the treatment of
The aim of the current study was therefore to investigate the antimicrobial and antibiofilm activities of a range of bacteria including organisms isolated from human skin, and the candidate probiotic E. coli Nissle 1917. E. coli Nissle 1917 is a commonly studied candidate probiotic bacterium.
LziYfmn.
  • 3827ejd1ci.pages.dev/480
  • 3827ejd1ci.pages.dev/561
  • 3827ejd1ci.pages.dev/17
  • 3827ejd1ci.pages.dev/38
  • 3827ejd1ci.pages.dev/400
  • 3827ejd1ci.pages.dev/84
  • 3827ejd1ci.pages.dev/579
  • 3827ejd1ci.pages.dev/185

    • escherichia coli nissle 1917 probiotic